STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Activity
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

35 hedge funds and large institutions have $897K invested in Statera Biopharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 6 closing their positions.

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
6
Closed
6
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$466K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$43K
3
BlackRock
3
BlackRock
New York
$32K
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$17K
5
TRCT
5
Tower Research Capital (TRC)
New York
$7K

Top Sellers

1
EAM
1
Empery Asset Management
New York
$0
2
VF
2
Virtu Financial
New York
$0
3
UBS Group
3
UBS Group
Switzerland
$2K
4
SM
4
Sabby Management
Florida
$0
5
TSS
5
Two Sigma Securities
New York
$3K
Name Holding Trade Value Shares
Change 		Shares
Change %
AIC
26
Archer Investment Corporation
Indiana
$86 – – –
EAM
27
Empery Asset Management
New York
– -$105K -333,016 Closed
VF
28
Virtu Financial
New York
– -$50K -157,678 Closed
SM
29
Sabby Management
Florida
– -$22K -69,103 Closed
HF
30
HRT Financial
New York
– -$7K -22,539 Closed
Citadel Advisors
31
Citadel Advisors
Florida
– -$7K -20,368 Closed
1
2